annual book value:
$16.41B-$1.17B(-6.66%)Summary
- As of today (April 25, 2025), VRTX annual book value is $16.41 billion, with the most recent change of -$1.17 billion (-6.66%) on December 31, 2024.
- During the last 3 years, VRTX annual book value has risen by +$6.31 billion (+62.47%).
- VRTX annual book value is now -6.66% below its all-time high of $17.58 billion, reached on December 31, 2023.
Performance
VRTX Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$16.41B+$778.70M(+4.98%)Summary
- As of today (April 25, 2025), VRTX quarterly book value is $16.41 billion, with the most recent change of +$778.70 million (+4.98%) on December 31, 2024.
- Over the past year, VRTX quarterly book value has dropped by -$1.17 billion (-6.66%).
- VRTX quarterly book value is now -11.52% below its all-time high of $18.55 billion, reached on March 31, 2024.
Performance
VRTX quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
VRTX Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | -6.7% |
| 3 y3 years | +62.5% | +25.9% |
| 5 y5 years | +169.7% | +25.9% |
VRTX Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | +62.5% | -11.5% | +50.5% |
| 5 y | 5-year | -6.7% | +169.7% | -11.5% | +153.9% |
| alltime | all time | -6.7% | >+9999.0% | -11.5% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $16.41B(-6.7%) | $16.41B(+5.0%) |
| Sep 2024 | - | $15.63B(+5.8%) |
| Jun 2024 | - | $14.77B(-20.3%) |
| Mar 2024 | - | $18.55B(+5.5%) |
| Dec 2023 | $17.58B(+26.4%) | $17.58B(+6.5%) |
| Sep 2023 | - | $16.51B(+6.7%) |
| Jun 2023 | - | $15.47B(+7.2%) |
| Mar 2023 | - | $14.43B(+3.7%) |
| Dec 2022 | $13.91B(+37.7%) | $13.91B(+6.8%) |
| Sep 2022 | - | $13.03B(+9.2%) |
| Jun 2022 | - | $11.93B(+9.4%) |
| Mar 2022 | - | $10.91B(+8.0%) |
| Dec 2021 | $10.10B(+16.3%) | $10.10B(+6.0%) |
| Sep 2021 | - | $9.53B(+3.6%) |
| Jun 2021 | - | $9.20B(+2.4%) |
| Mar 2021 | - | $8.98B(+3.4%) |
| Dec 2020 | $8.69B(+42.8%) | $8.69B(+6.8%) |
| Sep 2020 | - | $8.13B(+8.2%) |
| Jun 2020 | - | $7.52B(+16.4%) |
| Mar 2020 | - | $6.46B(+6.2%) |
| Dec 2019 | $6.09B(+37.2%) | $6.09B(+15.8%) |
| Sep 2019 | - | $5.25B(+3.6%) |
| Jun 2019 | - | $5.07B(+7.3%) |
| Mar 2019 | - | $4.72B(+6.5%) |
| Dec 2018 | $4.44B(+118.6%) | $4.44B(+52.6%) |
| Sep 2018 | - | $2.91B(+8.2%) |
| Jun 2018 | - | $2.69B(+11.9%) |
| Mar 2018 | - | $2.40B(+18.4%) |
| Dec 2017 | $2.03B(+75.4%) | $2.03B(+13.3%) |
| Sep 2017 | - | $1.79B(+7.2%) |
| Jun 2017 | - | $1.67B(+11.4%) |
| Mar 2017 | - | $1.50B(+29.7%) |
| Dec 2016 | $1.16B(+23.0%) | $1.16B(+13.2%) |
| Sep 2016 | - | $1.02B(+4.1%) |
| Jun 2016 | - | $981.35M(+2.5%) |
| Mar 2016 | - | $957.08M(+1.8%) |
| Dec 2015 | $939.97M(-12.6%) | $939.97M(+1.9%) |
| Sep 2015 | - | $922.15M(+3.0%) |
| Jun 2015 | - | $894.96M(-8.3%) |
| Mar 2015 | - | $976.46M(-9.2%) |
| Dec 2014 | $1.08B(-20.7%) | $1.08B(-7.0%) |
| Sep 2014 | - | $1.16B(-1.4%) |
| Jun 2014 | - | $1.17B(-4.8%) |
| Mar 2014 | - | $1.23B(-9.3%) |
| Dec 2013 | $1.36B(+35.8%) | $1.36B(+7.2%) |
| Sep 2013 | - | $1.26B(-4.4%) |
| Jun 2013 | - | $1.32B(+77.2%) |
| Mar 2013 | - | $746.12M(-25.3%) |
| Dec 2012 | $999.18M(+27.0%) | $999.18M(-2.8%) |
| Sep 2012 | - | $1.03B(-1.0%) |
| Jun 2012 | - | $1.04B(+11.5%) |
| Mar 2012 | - | $930.50M(+18.3%) |
| Dec 2011 | $786.84M(+56.1%) | $786.84M(+35.7%) |
| Sep 2011 | - | $579.76M(+88.5%) |
| Jun 2011 | - | $307.55M(-21.5%) |
| Mar 2011 | - | $391.67M(-22.3%) |
| Dec 2010 | $503.97M(-54.0%) | $503.97M(-22.5%) |
| Sep 2010 | - | $650.10M(-21.4%) |
| Jun 2010 | - | $827.13M(-16.5%) |
| Mar 2010 | - | $990.61M(-9.6%) |
| Dec 2009 | $1.10B(+359.0%) | $1.10B(+80.1%) |
| Sep 2009 | - | $608.74M(-16.5%) |
| Jun 2009 | - | $729.06M(+3.1%) |
| Mar 2009 | - | $706.85M(+195.9%) |
| Dec 2008 | $238.87M(-12.0%) | $238.87M(-31.7%) |
| Sep 2008 | - | $349.89M(+45.8%) |
| Jun 2008 | - | $239.93M(-21.1%) |
| Mar 2008 | - | $304.25M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $271.30M(-46.4%) | $271.30M(-18.3%) |
| Sep 2007 | - | $332.04M(-19.9%) |
| Jun 2007 | - | $414.58M(-17.3%) |
| Mar 2007 | - | $501.30M(-0.9%) |
| Dec 2006 | $505.94M(+111.5%) | $505.94M(-0.4%) |
| Sep 2006 | - | $507.77M(+190.2%) |
| Jun 2006 | - | $175.00M(-24.9%) |
| Mar 2006 | - | $232.91M(-2.6%) |
| Dec 2005 | $239.18M(+574.9%) | $239.18M(+79.4%) |
| Sep 2005 | - | $133.31M(+8.4%) |
| Jun 2005 | - | $122.96M(-1548.1%) |
| Mar 2005 | - | -$8.49M(-124.0%) |
| Dec 2004 | $35.44M(-81.6%) | $35.44M(-52.3%) |
| Sep 2004 | - | $74.32M(-32.6%) |
| Jun 2004 | - | $110.29M(-29.8%) |
| Mar 2004 | - | $157.10M(-18.5%) |
| Dec 2003 | $192.84M(-49.1%) | $192.84M(-16.6%) |
| Sep 2003 | - | $231.28M(-26.2%) |
| Jun 2003 | - | $313.52M(-21.7%) |
| Mar 2003 | - | $400.27M(+5.7%) |
| Dec 2002 | $378.58M(-20.4%) | $378.58M(-7.3%) |
| Sep 2002 | - | $408.21M(-6.5%) |
| Jun 2002 | - | $436.68M(-3.0%) |
| Mar 2002 | - | $450.11M(-5.3%) |
| Dec 2001 | $475.35M(-7.5%) | $475.35M(-0.2%) |
| Sep 2001 | - | $476.29M(+24.9%) |
| Jun 2001 | - | $381.35M(-2.4%) |
| Mar 2001 | - | $390.71M(-24.0%) |
| Dec 2000 | $514.01M(+145.7%) | $514.01M(+126.8%) |
| Sep 2000 | - | $226.60M(+0.7%) |
| Jun 2000 | - | $225.11M(+11.6%) |
| Mar 2000 | - | $201.74M(-3.6%) |
| Dec 1999 | $209.23M(-15.0%) | $209.23M(+1.3%) |
| Sep 1999 | - | $206.50M(-5.5%) |
| Jun 1999 | - | $218.60M(-4.7%) |
| Mar 1999 | - | $229.50M(-6.8%) |
| Dec 1998 | $246.20M(-10.8%) | $246.20M(-5.0%) |
| Sep 1998 | - | $259.10M(-0.1%) |
| Jun 1998 | - | $259.30M(-3.4%) |
| Mar 1998 | - | $268.40M(-2.8%) |
| Dec 1997 | $276.00M(+111.0%) | $276.00M(-2.0%) |
| Sep 1997 | - | $281.50M(-1.6%) |
| Jun 1997 | - | $286.00M(+3.9%) |
| Mar 1997 | - | $275.20M(+110.4%) |
| Dec 1996 | $130.80M(+53.3%) | $130.80M(-2.2%) |
| Sep 1996 | - | $133.70M(+116.7%) |
| Jun 1996 | - | $61.70M(-21.3%) |
| Mar 1996 | - | $78.40M(-8.1%) |
| Dec 1995 | $85.30M(-19.1%) | $85.30M(-0.4%) |
| Sep 1995 | - | $85.60M(-7.4%) |
| Jun 1995 | - | $92.40M(-8.4%) |
| Mar 1995 | - | $100.90M(-4.4%) |
| Dec 1994 | $105.50M(+113.1%) | $105.50M(+11.4%) |
| Sep 1994 | - | $94.70M(-4.4%) |
| Jun 1994 | - | $99.10M(-5.2%) |
| Mar 1994 | - | $104.50M(+111.1%) |
| Dec 1993 | $49.50M(+12.8%) | $49.50M(+21.9%) |
| Sep 1993 | - | $40.60M(-6.0%) |
| Jun 1993 | - | $43.20M(+6.4%) |
| Mar 1993 | - | $40.60M(-7.5%) |
| Dec 1992 | $43.90M(-15.9%) | $43.90M(-5.6%) |
| Sep 1992 | - | $46.50M(-4.3%) |
| Jun 1992 | - | $48.60M(-4.0%) |
| Mar 1992 | - | $50.60M(-3.1%) |
| Dec 1991 | $52.20M(+903.8%) | $52.20M(+87.8%) |
| Sep 1991 | - | $27.80M(+969.2%) |
| Jun 1991 | - | $2.60M(-50.0%) |
| Dec 1990 | $5.20M | $5.20M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual book value?
- What is the all time high annual book value for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual book value year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly book value?
- What is the all time high quarterly book value for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly book value year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual book value?
The current annual book value of VRTX is $16.41B
What is the all time high annual book value for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual book value is $17.58B
What is Vertex Pharmaceuticals Incorporated annual book value year-on-year change?
Over the past year, VRTX annual book value has changed by -$1.17B (-6.66%)
What is Vertex Pharmaceuticals Incorporated quarterly book value?
The current quarterly book value of VRTX is $16.41B
What is the all time high quarterly book value for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly book value is $18.55B
What is Vertex Pharmaceuticals Incorporated quarterly book value year-on-year change?
Over the past year, VRTX quarterly book value has changed by -$1.17B (-6.66%)